$AMOD
ALPHA MODUS HOLDINGS, INC.

2022 Q2 Form 10-Q Financial Statement

#000119312522221255 Filed on August 15, 2022

View on sec.gov

Income Statement

Concept 2022 Q2 2022 Q1 2021 Q4
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $339.5K $413.1K $341.9K
YoY Change 38480.68%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $388.8K $461.9K $393.4K
YoY Change 876.2%
Operating Profit -$388.8K -$461.9K
YoY Change 876.14%
Interest Expense $3.223M $3.841M $3.350M
YoY Change
% of Operating Profit
Other Income/Expense, Net $3.223M $3.841M -$4.150M
YoY Change
Pretax Income $2.834M $3.380M $2.986M
YoY Change -7215.94%
Income Tax $0.00
% Of Pretax Income 0.0%
Net Earnings $2.834M $3.379M $3.480M
YoY Change -7215.4%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $94.48K $112.7K $99.52K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q2 2022 Q1 2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $126.5K $569.4K $878.0K
YoY Change 406.0%
Cash & Equivalents $126.5K $569.4K $877.9K
Short-Term Investments
Other Short-Term Assets $571.4K $807.0K $876.0K
YoY Change
Inventory
Prepaid Expenses $571.4K $876.3K
Receivables
Other Receivables
Total Short-Term Assets $697.9K $1.376M $1.754M
YoY Change 2691.56%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $241.3M $241.1M $241.2M
YoY Change
Other Assets $83.33K $0.00
YoY Change -77.22%
Total Long-Term Assets $241.4M $241.1M $241.2M
YoY Change 65874.33%
TOTAL ASSETS
Total Short-Term Assets $697.9K $1.376M $1.754M
Total Long-Term Assets $241.4M $241.1M $241.2M
Total Assets $242.1M $242.5M $242.9M
YoY Change 61833.48%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $94.64K $119.4K $34.33K
YoY Change 55.4%
Accrued Expenses $72.44K $305.3K $156.0K
YoY Change -75.43%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $218.3K $424.6K $340.6K
YoY Change -46.21%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $15.86M $18.90M $264.0M
YoY Change
Total Long-Term Liabilities $15.86M $18.90M $264.0M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $218.3K $424.6K $340.6K
Total Long-Term Liabilities $15.86M $18.90M $264.0M
Total Liabilities $16.08M $19.32M $23.14M
YoY Change 3862.93%
SHAREHOLDERS EQUITY
Retained Earnings -$15.18M -$18.02M -$21.40M
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$15.18M -$18.02M -$21.39M
YoY Change
Total Liabilities & Shareholders Equity $242.1M $242.5M $242.9M
YoY Change 61833.48%

Cashflow Statement

Concept 2022 Q2 2022 Q1 2021 Q4
OPERATING ACTIVITIES
Net Income $2.834M $3.379M $3.480M
YoY Change -7215.4%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$442.9K -$223.5K -$169.7K
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 -85.00K -97.55K
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -442.9K -223.5K -169.7K
Cash From Investing Activities 0.000 0.000
Cash From Financing Activities 0.000 -85.00K -97.55K
Net Change In Cash -442.9K -308.5K -267.2K
YoY Change -1871.6%
FREE CASH FLOW
Cash From Operating Activities -$442.9K -$223.5K -$169.7K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Registrant Name
EntityRegistrantName
Insight Acquisition Corp. /DE
dei Entity Central Index Key
EntityCentralIndexKey
0001862463
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
inaq Loss From Investments Held In Trust Account
LossFromInvestmentsHeldInTrustAccount
-128821
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity File Number
EntityFileNumber
001-40775
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
86-3386030
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10128
dei Entity Address Address Line1
EntityAddressAddressLine1
333 East 91st Street
dei Entity Address City Or Town
EntityAddressCityOrTown
New York
dei City Area Code
CityAreaCode
917
dei Local Phone Number
LocalPhoneNumber
374-2922
dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
true
CY2022Q2 us-gaap Cash
Cash
126504
CY2021Q4 us-gaap Cash
Cash
877937
CY2022Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
571385
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
876317
CY2022Q2 us-gaap Assets Current
AssetsCurrent
697889
CY2021Q4 us-gaap Assets Current
AssetsCurrent
1754254
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
83334
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
0
CY2022Q2 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
241316750
CY2021Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
241187929
CY2022Q2 us-gaap Assets
Assets
242097973
CY2021Q4 us-gaap Assets
Assets
242942183
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
94639
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
34332
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
72436
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
155963
CY2022Q2 inaq Accrued Expenses Related Party Current
AccruedExpensesRelatedPartyCurrent
10000
CY2021Q4 inaq Accrued Expenses Related Party Current
AccruedExpensesRelatedPartyCurrent
10000
CY2022Q2 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
41181
CY2021Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
140274
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
218256
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
340569
CY2022Q2 inaq Deferred Underwriting Commissions Noncurrent
DeferredUnderwritingCommissionsNoncurrent
12000000
CY2021Q4 inaq Deferred Underwriting Commissions Noncurrent
DeferredUnderwritingCommissionsNoncurrent
12000000
CY2022Q2 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
3860520
CY2021Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
10796190
CY2022Q2 us-gaap Liabilities
Liabilities
16078776
CY2021Q4 us-gaap Liabilities
Liabilities
23136759
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
0
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
0
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-15181493
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-21395266
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-15180803
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-21394576
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
242097973
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
242942183
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
339509
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
752586
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
879
CY2022Q2 us-gaap Taxes Other
TaxesOther
49315
us-gaap Taxes Other
TaxesOther
98132
CY2021Q2 us-gaap Taxes Other
TaxesOther
38954
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-388824
us-gaap Operating Income Loss
OperatingIncomeLoss
-850718
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-39833
CY2022Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-3036600
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-6935670
CY2021Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0
CY2022Q2 inaq Loss From Investments Held In Trust Account
LossFromInvestmentsHeldInTrustAccount
-186500
inaq Loss From Investments Held In Trust Account
LossFromInvestmentsHeldInTrustAccount
-128821
CY2021Q2 inaq Loss From Investments Held In Trust Account
LossFromInvestmentsHeldInTrustAccount
0
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3223100
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
7064491
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
2834276
us-gaap Net Income Loss
NetIncomeLoss
6213773
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-39833
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-21394576
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
3379497
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-18015079
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
2834276
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-15180803
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
0
CY2021Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
25000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-39833
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-14833
us-gaap Net Income Loss
NetIncomeLoss
6213773
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-39833
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-6935670
CY2021Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0
CY2021Q2 inaq Loss From Investments Held In Trust Account
LossFromInvestmentsHeldInTrustAccount
0
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-221598
CY2021Q2 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
0
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
60307
CY2021Q2 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
879
inaq Increase Decrease In Accrued Expense Related Party
IncreaseDecreaseInAccruedExpenseRelatedParty
1473
CY2021Q2 inaq Increase Decrease In Accrued Expense Related Party
IncreaseDecreaseInAccruedExpenseRelatedParty
0
us-gaap Increase Decrease In Property And Other Taxes Payable
IncreaseDecreaseInPropertyAndOtherTaxesPayable
-99093
CY2021Q2 us-gaap Increase Decrease In Property And Other Taxes Payable
IncreaseDecreaseInPropertyAndOtherTaxesPayable
38954
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-666433
CY2021Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
0
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0
CY2021Q2 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
25000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
85000
CY2021Q2 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-85000
CY2021Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
25000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-751433
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
25000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
877937
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
126504
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
25000
us-gaap Stock Issued1
StockIssued1
0
CY2021Q2 us-gaap Stock Issued1
StockIssued1
25000
inaq Offering Costs Included In Accounts Payable
OfferingCostsIncludedInAccountsPayable
0
CY2021Q2 inaq Offering Costs Included In Accounts Payable
OfferingCostsIncludedInAccountsPayable
60020
inaq Offering Costs Included In Accrued Expenses
OfferingCostsIncludedInAccruedExpenses
0
CY2021Q2 inaq Offering Costs Included In Accrued Expenses
OfferingCostsIncludedInAccruedExpenses
255875
inaq Offering Costs Paid Through Note Payable Related Party
OfferingCostsPaidThroughNotePayableRelatedParty
0
CY2021Q2 inaq Offering Costs Paid Through Note Payable Related Party
OfferingCostsPaidThroughNotePayableRelatedParty
25000
dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2021-04-20
CY2021Q3 inaq Restrictedinvestmentsterm
Restrictedinvestmentsterm
P185D
CY2022Q2 us-gaap Share Price
SharePrice
10.05
CY2022Q2 us-gaap Minimum Net Worth Required For Compliance
MinimumNetWorthRequiredForCompliance
5000001
CY2022Q2 inaq Percentage Of Public Shares To Be Redeemed On Non Completion Of Business Combination
PercentageOfPublicSharesToBeRedeemedOnNonCompletionOfBusinessCombination
1
inaq Lock In Period For Redemption Of Public Shares After Closing Of Ipo
LockInPeriodForRedemptionOfPublicSharesAfterClosingOfIpo
P18M
CY2022Q2 us-gaap Liquidation Basis Of Accounting Accrued Costs To Dispose Of Assets And Liabilities
LiquidationBasisOfAccountingAccruedCostsToDisposeOfAssetsAndLiabilities
100000
CY2022Q2 inaq Minimum Share Price Of The Residual Assets Remaining Available For Distribution
MinimumSharePriceOfTheResidualAssetsRemainingAvailableForDistribution
10.05
CY2022Q2 us-gaap Cash
Cash
127000
CY2022Q2 inaq Working Capital Deficit
WorkingCapitalDeficit
563000000000
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
25000
us-gaap Proceeds From Unsecured Notes Payable
ProceedsFromUnsecuredNotesPayable
163000
CY2021Q3 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
157000
CY2021Q3 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
6000
CY2022Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2021Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Concentration of Credit Risk </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. As of June 30, 2022 and December 31, 2021, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. </div></div>
CY2022Q2 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Use of Estimates </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The preparation of condensed financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed financial statements and the reported amounts of income and expenses during the reporting period. Making estimates requires management to exercise significant judgment. One of the more significant accounting estimates included in these condensed financial statements is the determination of the fair value of the warrant liabilities. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. </div></div>
inaq Term Of Restricted Investments
TermOfRestrictedInvestments
P185D
CY2022Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued
0
CY2021Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued
0
CY2022Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2022Q2 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
24000000
CY2022Q2 us-gaap Temporary Equity Value Excluding Additional Paid In Capital
TemporaryEquityValueExcludingAdditionalPaidInCapital
0.0001
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0

Files In Submission

Name View Source Status
0001193125-22-221255-index-headers.html Edgar Link pending
0001193125-22-221255-index.html Edgar Link pending
0001193125-22-221255.txt Edgar Link pending
0001193125-22-221255-xbrl.zip Edgar Link pending
d346934d10q.htm Edgar Link pending
d346934dex311.htm Edgar Link pending
d346934dex312.htm Edgar Link pending
d346934dex321.htm Edgar Link pending
d346934dex322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
inaq-20220630.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
inaq-20220630_cal.xml Edgar Link unprocessable
inaq-20220630_def.xml Edgar Link unprocessable
inaq-20220630_lab.xml Edgar Link unprocessable
inaq-20220630_pre.xml Edgar Link unprocessable
d346934d10q_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable